NYSEAMERICAN:OCX - OncoCyte Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.30 -0.05 (-2.13 %)
(As of 06/21/2018 04:00 PM ET)
Previous Close$2.35
Today's Range$2.25 - $2.45
52-Week Range$1.10 - $7.64
Volume37,900 shs
Average Volume60,659 shs
Market Capitalization$67.57 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OncoCyte logoOncoCyte Corporation focuses on the development and commercialization of novel and non-invasive blood and urine (liquid biopsy) diagnostic tests for the early detection of cancer. The company is developing diagnostic tests using genetic and protein markers expressed in various types of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer. The company was founded in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime, Inc.

Receive OCX News and Ratings via Email

Sign-up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:OCX
CUSIPN/A
Phone+1-510-7750515

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-404.76%
Return on Assets-209.93%

Miscellaneous

EmployeesN/A
Outstanding Shares39,400,000

OncoCyte (NYSEAMERICAN:OCX) Frequently Asked Questions

What is OncoCyte's stock symbol?

OncoCyte trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OCX."

How were OncoCyte's earnings last quarter?

OncoCyte Corp (NYSEAMERICAN:OCX) posted its quarterly earnings data on Tuesday, May, 15th. The biotechnology company reported ($0.12) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.13) by $0.01. View OncoCyte's Earnings History.

When is OncoCyte's next earnings date?

OncoCyte is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for OncoCyte.

Are investors shorting OncoCyte?

OncoCyte saw a decrease in short interest in the month of May. As of May 31st, there was short interest totalling 619,924 shares, a decrease of 11.9% from the May 15th total of 703,376 shares. Based on an average daily volume of 45,906 shares, the short-interest ratio is presently 13.5 days. Approximately 3.3% of the company's stock are sold short. View OncoCyte's Current Options Chain.

Who are some of OncoCyte's key competitors?

Who are OncoCyte's key executives?

OncoCyte's management team includes the folowing people:
  • Mr. William Annett, Pres, CEO & Director (Age 64)
  • Dr. Kristine C. Mechem Ph.D., VP of Marketing & Planninng
  • Dr. Lyndal K. Hesterberg Ph.D., Sr. VP of R&D
  • Mr. Mitchell S. Levine, Chief Financial Officer
  • Mr. Michael G. Vicari, VP of Sales

Has OncoCyte been receiving favorable news coverage?

Media headlines about OCX stock have trended positive this week, according to Accern Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. OncoCyte earned a news impact score of 0.28 on Accern's scale. They also gave media coverage about the biotechnology company an impact score of 46.34 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of OncoCyte?

Shares of OCX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OncoCyte's stock price today?

One share of OCX stock can currently be purchased for approximately $2.30.

How big of a company is OncoCyte?

OncoCyte has a market capitalization of $67.57 million.

How can I contact OncoCyte?

OncoCyte's mailing address is 1010 Atlantic Ave Ste 102, ALAMEDA, CA 94501-1147, United States. The biotechnology company can be reached via phone at +1-510-7750515.


MarketBeat Community Rating for OncoCyte (OCX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about OncoCyte and other stocks. Vote "Outperform" if you believe OCX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.